Omega Diagnostics Group PLC – LSE:ODX.L
Omega Diagnostics Group stock price today
Omega Diagnostics Group stock price monthly change
Omega Diagnostics Group stock price quarterly change
Omega Diagnostics Group stock price yearly change
Omega Diagnostics Group key metrics
Market Cap | 4.94M |
Enterprise value | 386.91M |
P/E | -1.55 |
EV/Sales | 39.40 |
EV/EBITDA | -56.12 |
Price/Sales | 0.40 |
Price/Book | 0.33 |
PEG ratio | N/A |
EPS | -0.02 |
Revenue | 9.28M |
EBITDA | -2.68M |
Income | -2.92M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -69.54% |
Oper. margin | 7.15% |
Gross margin | 64.1% |
EBIT margin | 7.15% |
EBITDA margin | -28.95% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOmega Diagnostics Group stock price history
Omega Diagnostics Group stock forecast
Omega Diagnostics Group financial statements
| Mar 2019 | 2.18M | 243.56K | 11.13% |
|---|---|---|---|
| Jun 2019 | 2.18M | 243.56K | 11.13% |
| Jun 2020 | 2.45M | -1.70M | -69.54% |
| Sep 2020 | 2.45M | -1.70M | -69.54% |
| Sep 2020 | 28447868 | 4.50M | 15.83% |
|---|---|---|---|
| Mar 2021 | 30989455 | 7.31M | 23.61% |
| Sep 2021 | 28902000 | 8.32M | 28.8% |
| Sep 2022 | 17130000 | 5.32M | 31.1% |
| Jan 2020 | 136.90K | -538.46K | 585.84K |
|---|---|---|---|
| Mar 2020 | 136.90K | -538.46K | 585.84K |
| Jun 2020 | 136.90K | -538.46K | 585.84K |
| Sep 2020 | 136.90K | -538.46K | 585.84K |
Omega Diagnostics Group alternative data
| Aug 2023 | 85 |
|---|---|
| Sep 2023 | 91 |
| Oct 2023 | 91 |
| Nov 2023 | 91 |
| Dec 2023 | 91 |
| Jan 2024 | 91 |
| Feb 2024 | 91 |
| Mar 2024 | 91 |
| Apr 2024 | 91 |
| May 2024 | 91 |
| Jun 2024 | 91 |
| Jul 2024 | 91 |
Omega Diagnostics Group other data
| Insider | Compensation |
|---|---|
Mr. Colin King (1969) Chief Executive Officer & Executive Director | $217,150 |
Mr. Jagdeep Grewal (1969) MD of the Health & Nutrition Division and Executive Director | $154,690 |
-
What's the price of Omega Diagnostics Group stock today?
One share of Omega Diagnostics Group stock can currently be purchased for approximately $27.25.
-
When is Omega Diagnostics Group's next earnings date?
Unfortunately, Omega Diagnostics Group's (ODX.L) next earnings date is currently unknown.
-
Does Omega Diagnostics Group pay dividends?
No, Omega Diagnostics Group does not pay dividends.
-
How much money does Omega Diagnostics Group make?
Omega Diagnostics Group has a market capitalization of 4.94M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2.24% to 8.54M US dollars.
-
What is Omega Diagnostics Group's stock symbol?
Omega Diagnostics Group PLC is traded on the LSE under the ticker symbol "ODX.L".
-
What is Omega Diagnostics Group's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Omega Diagnostics Group?
Shares of Omega Diagnostics Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Omega Diagnostics Group's key executives?
Omega Diagnostics Group's management team includes the following people:
- Mr. Colin King Chief Executive Officer & Executive Director(age: 56, pay: $217,150)
- Mr. Jagdeep Grewal MD of the Health & Nutrition Division and Executive Director(age: 56, pay: $154,690)
-
How many employees does Omega Diagnostics Group have?
As Jul 2024, Omega Diagnostics Group employs 91 workers.
-
When Omega Diagnostics Group went public?
Omega Diagnostics Group PLC is publicly traded company for more then 21 years since IPO on 19 Mar 2004.
-
What is Omega Diagnostics Group's official website?
The official website for Omega Diagnostics Group is omegadiagnostics.com.
-
How can i contact Omega Diagnostics Group?
Omega Diagnostics Group can be reached via phone at +44 1259 763030.
Omega Diagnostics Group company profile:
Omega Diagnostics Group PLC
omegadiagnostics.comLSE
91
Medical - Instruments & Supplies
Healthcare
Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company operates through two segments, Health and Nutrition, and Global Health and Other. The Health and Nutrition segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Global Health and Other segment engages in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment offers VISITECT CD4, an advanced disease rapid test, which is used to treat patients with HIV; and AbC-19, a COVID-19 antibody testing kit, as well as COVID-19 antigen and antibody testing solutions. The company offers its products to hospitals, clinics, laboratories, and healthcare practitioners through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.
Alva, FK12 5DQ
:
ISIN: GB00B1VCP282
CUSIP: G6769Y106
